Pharmacologic Agents That Promote Airway Clearance in Hospitalized Subjects: A Systematic Review

References

1. 1.↵
   1. Rogers DF

   . Mucoactive agents for airway mucus hypersecretory diseases. Respir Care 52(9):1176–1193, 2007; discussion 1193-1177.

   OpenUrlAbstract/FREE Full Text
2. 2.↵
   1. Balsamo R,
   2. Lanata L,
   3. Egan CG

   . Mucoactive drugs. Eur Respir Rev 2010;19(116):127–133.

   OpenUrlAbstract/FREE Full Text
3. 3.↵
   1. Bhowmik A,
   2. Chahal K,
   3. Austin G,
   4. Chakravorty I

   . Improving mucociliary clearance in chronic obstructive pulmonary disease. Respir Med 2009;103(4):496–502.

   OpenUrlCrossRefPubMed
4. 4.↵
   1. Sadowska AM,
   2. Verbraecken J,
   3. Darquennes K,
   4. De Backer WA

   . Role of N-acetylcysteine in the management of COPD. Int J Chron Obstruct Pulmon Dis 2006;1(4):425–434.

   OpenUrlPubMed
5. 5.↵
   1. Rubin BK

   . The pharmacologic approach to airway clearance: mucoactive agents. Paediatr Respir Rev 2006;7(Suppl 1):S215–S219.

   OpenUrlPubMed
6. 6.↵
   1. Rubin BK

   . Mucolytics, expectorants, and mucokinetic medications. Respir Care 2007;52(7):859–865.

   OpenUrlAbstract/FREE Full Text
7. 7.↵
   1. Ramos FL,
   2. Krahnke JS,
   3. Kim V

   . Clinical issues of mucus accumulation in COPD. Int J Chron Obstruct Pulmon Dis 2014;9:139–150.

   OpenUrlPubMed
8. 8.↵
   1. Andrews J,
   2. Sathe NA,
   3. Krishnaswami S,
   4. McPheeters ML

   . Nonpharmacologic airway clearance techniques in hospitalized patients: a systematic review. Respir Care 2013;58(12):2160–2186.

   OpenUrlAbstract/FREE Full Text
9. 9.↵
   1. Flume PA,
   2. Robinson KA,
   3. O'Sullivan BP,
   4. Finder JD,
   5. Vender RL,
   6. Willey-Courand DB,
   7. et al

   . Cystic fibrosis pulmonary guidelines: airway clearance therapies. Respir Care 2009;54(4):522–537.

   OpenUrlAbstract/FREE Full Text
10. 10.↵
    1. Thomas PA,
    2. Lynch RE,
    3. Merrigan EH

    . Prevention of postoperative pulmonary atelectasis: review of 215 cases and evaluation of acetylcysteine. Am Surg 1966;32(5):301–307.

    OpenUrlPubMed
11. 11.↵
    1. O'Riordan TG,
    2. Mao W,
    3. Palmer LB,
    4. Chen JJ

    . Assessing the effects of racemic and single-enantiomer albuterol on airway secretions in long-term intubated patients. Chest 2006;129(1):124–132.

    OpenUrlCrossRefPubMed
12. 12.↵
    1. Pulle DF,
    2. Glass P,
    3. Dulfano MJ

    . A controlled study of the safety and efficacy of acetylcysteine-isoproterenol combination. Curr Ther Res Clin Exp 1970;12(8):485–492.

    OpenUrlPubMed
13. 13.↵
    1. Desai MH,
    2. Mlcak R,
    3. Richardson J,
    4. Nichols R,
    5. Herndon DN

    . Reduction in mortality in pediatric patients with inhalation injury with aerosolized heparin/N-acetylcystine therapy. J Burn Care Rehabil 1998;19(3):210–212.

    OpenUrlCrossRefPubMedWeb of Science
14. 14.↵
    1. May CS,
    2. Palmer KN

    . Effect of aerosol ipratropium bromide (SCH 1000) on sputum viscosity and volume in chronic bronchitis. Br J Clin Pharmacol 1977;4(4):491–492.

    OpenUrlPubMed
15. 15.↵
    1. Jepsen S,
    2. Klaerke A,
    3. Nielsen PH,
    4. Nielsen ST,
    5. Simonsen O

    . Systemic administration of N-acetylcysteine has no effect on postoperative lung function following elective upper laparotomy in lung healthy patients. Acta Anaesthesiol Scand 1989;33(3):219–222.

    OpenUrlPubMed
16. 16.↵
    1. Aliyali M,
    2. Poorhasan Amiri A,
    3. Sharifpoor A,
    4. Zalli F

    . Effects of N-acetylcysteine on asthma exacerbation. Iran J Allergy Asthma Immunol 2010;9(2):103–109.

    OpenUrlPubMed
17. 17.↵
    1. Black PN,
    2. Morgan-Day A,
    3. McMillan TE,
    4. Poole PJ,
    5. Young RP

    . Randomised, controlled trial of N-acetylcysteine for treatment of acute exacerbations of chronic obstructive pulmonary disease [ISRCTN21676344]. BMC Pulmon Med 2004;4:13.

    OpenUrl
18. 18.↵
    1. Wilkinson M,
    2. Sugumar K,
    3. Milan SJ,
    4. Hart A,
    5. Crockett A,
    6. Crossingham I

    . Mucolytics for bronchiectasis. Cochrane Database Syst Rev 2014;5:CD001289.

    OpenUrlPubMed
19. 19.
    1. Poole P,
    2. Black PN,
    3. Cates CJ

    . Mucolytic agents for chronic bronchitis or chronic obstructive pulmonary disease. Cochrane Database Syst Rev 2012;8:CD001287.

    OpenUrlPubMed
20. 20.↵
    1. De Coster DA,
    2. Jones M,
    3. Thakrar N

    . Beclometasone for chronic obstructive pulmonary disease. Cochrane Database Syst Rev 2013;10:CD009769.

    OpenUrlPubMed